Showing results (51-60 of 352) with videos related to
Sort By:
Pageof 36
Scientific Reports|May 28, 2015
A statistical framework to predict functional non-coding regions in the human genome through integrated analysis of annotation dataQiongshi Lu, Yiming Hu, Jiehuan Sun, et al.Plos Neglected Tropical Diseases|May 25, 2022
Estimates of Japanese Encephalitis mortality and morbidity: A systematic review and modeling analysisYuwei Cheng, Nhat Tran Minh, Quan Tran Minh, et al.Journal of Adolescence|May 22, 2018
School climate and physical adolescent relationship abuse: Differences by sex, socioeconomic status, and bullyingSonia Jain, Alison K Cohen, Taylor Paglisotti, et al.The Pediatric Infectious Disease Journal|August 6, 2011
Evolution of laboratory values in patients with Kawasaki diseaseAdriana H Tremoulet, Sonia Jain, Divya Chandrasekar, et al.Cancer Research|October 6, 2005
Atm heterozygosity cooperates with loss of Brca1 to increase the severity of mammary gland cancer and reduce ductal branchingT J Bowen, Hiroyuki Yakushiji, Cristina Montagna, et al.Open Forum Infectious Diseases|January 25, 2020
Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Patients With HIV InfectionJuliana Sobczyk, Sonia Jain, Xiaoying Sun, et al.Journal of the American Heart Association|December 28, 2019
Biomarkers of Inflammation and Fibrosis in Kawasaki Disease Patients Years After Initial Presentation With Low Ejection FractionShinsuke Hoshino, Chisato Shimizu, Sonia Jain, et al.AIDS and Behavior|January 25, 2015
Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEPJill Blumenthal, Sonia Jain, Douglas Krakower, et al.Plos One|March 14, 2013
Differential expression of miR-145 in children with Kawasaki diseaseChisato Shimizu, Jihoon Kim, Petra Stepanowsky, et al.Pediatric Blood & Cancer|November 17, 2022
Cardiovascular toxicities with pediatric tyrosine kinase inhibitor therapy: An analysis of adverse events reported to the Food and Drug AdministrationHari K Narayan, Karyn Sheline, Victor Wong, et al.Pageof 36